Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
2003 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Plasma BNP levels in the treatment of type 2 diabetes with pioglitazone.
Ogawa S, Takeuchi K, Ito S. Ogawa S, et al. J Clin Endocrinol Metab. 2003 Aug;88(8):3993-6. doi: 10.1210/jc.2002-021765. J Clin Endocrinol Metab. 2003. PMID: 12915698 Clinical Trial.
We also examined those levels in no drug-treatment group (n = 10) as well as buformine treatment group (n = 10). Among these groups, there were no significant differences in clinical profiles related to DM control. ...
We also examined those levels in no drug-treatment group (n = 10) as well as buformine treatment group (n = 10). Among these groups, …
[Treatment of primary hyperlipoproteinemias type IV with different biguanides (author's transl)].
Weisweiler P, Schwandt P. Weisweiler P, et al. Klin Wochenschr. 1976 Mar 15;54(6):283-5. doi: 10.1007/BF01468924. Klin Wochenschr. 1976. PMID: 177803 Clinical Trial. German.
In 12 patients with primary type IV hyperlipoproteinemia the lipid lowering effect of constant doses of the biguanides metformin, phenformin and buformin was compared. After a 2 months dietary period bodyweight and initial triglyceride and cholesterol plasma concentrations …
In 12 patients with primary type IV hyperlipoproteinemia the lipid lowering effect of constant doses of the biguanides metformin, phenformin …